Biotech Sector Turns Red-Hot on Alzheimer’s Treatment News In Phase 3 trials, a Biogen / Eisai Alzheimer’s drug slowed cognitive decline by 27%. 8 MIN READ 10.23.2022
Critical To Assess the Market’s Risk-Reward Proposition It's important to consider what happens when the Fed stops fueling the bubble. 7 MIN READ 05.16.2020
Speculative Opportunities In The Senior Tech Market How should the rapid growth of the senior demographic affect your investment strategy? 5 MIN READ 03.4.2019
Athenex and MAIA Get Approval for Generic Levothyroxine for Hypothyroidism Hypothyroidism affects 4.6% of the US population aged 12 and older (Image: NIH) 4 MIN READ 12.26.2018
Sutro Biopharma Achieves Another Milestone in Celgene Partnership Latest $10 million payment from Celgene triggered by development of spray drying technology that advances commercial-scale manufacturing (Image: Sutro Biopharma). 3 MIN READ 12.19.2018
Critical To Assess the Market’s Risk-Reward Proposition